Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px

News > All

Total search results: 7677 | Ordered by Date (descending)
1 2 3 ... 75 76 77  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Biotimus S.A.S.. (2/20/24). "Press Release: Ex-Google DeepMind and Owkin Scientists Team up to Create Bioptimus to Build the First Universal AI Foundation Model for Biology". 2024-02-20
Omnix Medical Ltd.. (2/20/24). "Press Release: Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6". Jerusalem. 2024-02-20
Evonik. (2/20/24). "Press Release: Evonik Partners with the University of Mainz to Commercialize a New Class of PEG Lipids for Nucleic Acid Delivery". Essen. 2024-02-20
Freenome, Inc.. (2/15/24). "Press Release: Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection". South San Francisco, CA. 2024-02-15
Firefly Bio, Inc.. (2/15/24). "Press Release: Firefly Bio Debuts with $94 Million Series A Financing". South San Francisco, CA. 2024-02-15
SAFIA Technologies GmbH. (2/15/24). "Press Release: Sysmex Partec and SAFIA Technologies. Pioneering Mycotoxin Analysis". Görlitz & Berlin. 2024-02-15
Earlybird VC Management GmbH & Co KG. (2/14/24). "Press Release: Earlybird Health Closes Fresh Fund of EUR 173m". Berlin & Cologne. 2024-02-14
MTIP AG. (2/14/24). "Press Release: MTIP Invests $15 Million in Caresyntax". 2024-02-14
CRISPR Therapeutics AG. (2/13/24). "Press Release: CRISPR Therapeutics Announces $280 Million Registered Direct Offering". Zug & Boston, MA. 2024-02-13
BioAge Labs. (2/13/24). "Press Release: BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics". Richmond, CA. 2024-02-13
Scinai Immunotherapeutics Ltd.. (2/13/24). "Press Release: Scinai Welcomes Liat Halpert as Head of Business Development and Sales". Jerusalem. 2024-02-13
VantAI. (2/13/24). "Press Release: VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence". New York, NY. 2024-02-13
Candriam. (2/13/24). "Press Release: Candriam Strengthens Thematic Investing Expertise with New Appointments and Announces Leadership Transition". London. 2024-02-13
CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z 2024-02-13
Repare Therapeutics Inc.. (2/12/24). "Press Release: Repare Therapeutics to Regain Global Rights to Camonsertib". Cambridge, MA & Montréal. 2024-02-12
T-Curx GmbH. (2/9/24). "Press Release: T-Curx Extends Its Management Team with Marion Jung, PhD, as Its New Chief Operating Officer". 2024-02-09
Sensorion S.A.. (2/9/24). "Press Release: Sensorion Announces a €50.5 Million Financing with Participation from New and Existing US and European Healthcare Specialist Investors [ not for US, et al.; only for qualified persons]". Montpellier. 2024-02-09
GenSight Biologics S.A.. (2/8/24). "Press Release: GenSight Biologics Announces Completion of a €5 million capital Increase with Sofinnova Partners, Invus, UPMC Enterprises and Heights Capital". Paris. 2024-02-08
Zetta Genomics Ltd.. (2/8/24). "Press Release: Zetta Genomics Expands Second Seed Funding Round with Additional £1.8 Million". 2024-02-08
Israel Advanced Technology Industries (IATI). (2/8/24). "Press Release: MIXiii Health-Tech.IL Annual Conference to Showcase Resilience and Growth of Israel's Life Sciences Industry Amid War". Herzliya. 2024-02-08
VantAI. (2/7/24). "Press Release: VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer". New York, NY. 2024-02-07
MorphoSys AG. (2/5/24). "Press Release: MorphoSys Enters into Business Combination Agreement to Be Acquired by Novartis for € 2.7 Billion Equity Value. Tafasitamab Sold to Incyte". Planegg. 2024-02-05
Silence Therapeutics plc. (2/5/24). "Press Release: Silence Therapeutics Announces Oversubscribed $120 Million Private Placement". London. 2024-02-05
ITM Isotope Technologies Munich SE. (2/1/24). "Press Release: ITM Obtains Manufacturing License in the U.S.". Garching & Princeton, NJ. 2024-02-01
Nadmed Oy. (2/1/24). "Press Release: Effortless Measurement of All Four NADs and Glutathione for Laboratories". 2024-02-01
Gilead Sciences, Inc.. (2/1/24). "Press Release: Ted Love, MD, Joins Gilead Sciences’ Board of Directors". Foster City, CA. 2024-02-01
Silence Therapeutics plc. (1/31/24). "Press Release: Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference". London. 2024-01-31
BioNTech SE. (1/31/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305". Mainz & Shanghai. 2024-01-31
ITM Isotope Technologies Munich SE. (1/30/24). "Press Release: ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program". Garching & Vancouver, BC. 2024-01-30
Aion Labs. (1/30/24). "Press Release: Aion Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery". Rehovot. 2024-01-30
BioIndustry Assocation (BIA). (1/30/24). "Press Release: BIA Reaches 600 Member Companies, Announces New Board and Leadership Restructure". Paris. 2024-01-30
Enterprise Therapeutics Ltd.. (1/30/24). "Press Release: Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing". Brighton. 2024-01-30
Hookipa Pharma Inc.. (1/29/24). "Press Release: Hookipa Pharma Provides Update on Business Priorities and Oncology Partnership Programs". New York, NY & Vienna. 2024-01-29
SGS S.A.. (1/26/24). "Press Release: Géraldine Picaud to Succeed Frankie Ng as Chief Executive Officer". 2024-01-26
SGS S.A.. (1/26/24). "Press Release: SGS 2023 Full Year Results and Strategic Update". 2024-01-26
Repare Therapeutics Inc.. (1/25/24). "Press Release: Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment". Cambridge, MA & Montréal. 2024-01-25
IMU Bioscience (Melio Health UK Ltd.). (1/24/24). "Press Release: IMU Biosciences Secures £11.5 Million in Series A Funding to Revolutionise Immune Powered Precision Medicine". London. 2024-01-24
Prism BioLab Co., Ldt.. (1/24/24). "Press Release: Prism BioLab Raises 1.5 Billion Yen in Series C Fundraising to Advance Technologies and Programs Targeting Protein-protein Interactions". Tokyo. 2024-01-24
BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London. 2024-01-24
Bruker Corporation. (1/23/24). "Press Release: Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts". Zürich & Newton, MA. 2024-01-23
BioLizard N.V.. (1/23/24). "Press Release: BioLizard Opens Office in Switzerland – AI-powered Digital Transformation of Life Sciences at Biopôle in Lausanne". Lausanne & Ghent. 2024-01-23
Bristol Myers Squibb Company. (1/23/24). "Press Release: Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio". Princeton, NJ. 2024-01-23
BioNTech SE. (1/22/24). "Press Release: BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer". Mainz & Shanghai. 2024-01-22
ReiThera S.r.l.. (1/22/24). "Press Release: ReiThera Srl, the Ragon Institute and IAVI Announce Collaboration to Advance Highly Networked T Cell HIV Vaccine Candidate Towards Phase I Clinical Evaluation". Rome & Cambridge, MA. 2024-01-22
Transgene S.A.. (1/22/24). "Press Release: Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer". Strasbourg. 2024-01-22
Mirae Asset Capital Life Science. (1/18/24). "Press Release: Mirae Asset Capital Life Science Emerges from Stealth with $50M Fund". Boston, MA & San Francisco, CA. 2024-01-18
CureVac N.V.. (1/17/24). "Press Release: CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock". Tübingen & Boston, MA. 2024-01-17
Disco Pharmaceuticals GmbH. (1/16/24). "Press Release: Disco Pharmaceuticals Launches as the Surfaceome Company with EUR 20 Million in Seed Financing". Cologne & Zurich. 2024-01-16
WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai. 2024-01-11
GSK plc. (1/9/24). "Press Release: GSK Enters Agreement to Acquire Aiolos Bio". 2024-01-09
BioNTech SE. (1/9/24). "Press Release: BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference". Mainz. 2024-01-09
Forbion Capital Partners. (1/9/24). "Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion". 2024-01-09
Catalym GmbH. (1/9/24). "Press Release: Catalym Appoints Drug Development Leader Roy Baynes to its Board of Directors and Strengthens Scientific Advisory Board with Three Accomplished Lung and Bladder Cancer Specialists". Mainz. 2024-01-09
Calypso Biotech B.V.. (1/8/24). "Press Release: Calypso Enters into Agreement to Be Acquired by Novartis". Amsterdam. 2024-01-08
CellPhenomics GmbH. (1/8/24). "Press Release: CellPhenomics and Charles River Announce Agreement, Expanding 3D in vitro Services for Cancer Therapy Drug Screening". Berlin & Wilmington, MA. 2024-01-08
Merck & Co., Inc.. (1/8/24). "Press Release: Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline". Rahway, NJ & South San Francisco, CA. 2024-01-08
Johnson & Johnson. (1/8/24). "Press Release: Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer". New Brunswick, NJ. 2024-01-08
Eckert & Ziegler AG. (1/8/24). "Press Release: Eckert & Ziegler and ArtBio Announce Manufacturing and Supply Partnership for Lead-212 Conjugates". Berlin & Cambridge, MA. 2024-01-08
Aion Labs. (1/8/24). "Press Release: Aion Labs Welcomes Amiti as Strategic Partner to Accelerate Israel's Position as a Leading Hub for Transformative AI-Powered Drug Discovery Innovation". Rehovot. 2024-01-08
Delfi Diagnostics, Inc.. (1/5/24). "Press Release: Delfi Diagnostics Appoints Susan Tousi as New Chief Executive Officer". Baltimore, MD & Palo Alto, CA. 2024-01-05
Twist Bioscience Corporation. (1/5/24). "Press Release: Twist Bioscience Appoints Adam Laponis as Chief Financial Officer". South San Francisco, CA. 2024-01-05
CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA. 2024-01-05
SanReno Therapeutics. (1/5/24). "Press Release: SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease". Shanghai. 2024-01-05
Immunic, Inc.. (1/5/24). "Press Release: Immunic, Inc. Announces Private Placement of up to $240 Million". New York, NY. 2024-01-05
GlycoEra AG. (1/5/24). "Press Release: GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer". Newton, MA & Wädenswil. 2024-01-05
Novo Nordisk A/S. (1/4/24). "Press Release: Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases". Bagsværd, Cambridge, MA & Somerville, MA. 2024-01-04
Evotec SE. (1/4/24). "Press Release: Evotec and Owkin Enter an A.I.-powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I". Hamburg & Paris. 2024-01-04
Qiagen N.V.. (1/4/24). "Press Release: Qiagen to Accelerate Investments into Qiagen Digital Insights Bioinformatics Business". Venlo. 2024-01-04
Menarini Group. (1/4/24). "Press Release: Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications". Florence & New York, NY. 2024-01-04
Human Immunology Biosciences, Inc. (HI-Bio). (1/4/24). "Press Release: HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases". South San Francisco, CA. 2024-01-04
Boehringer Ingelheim. (1/4/24). "Press Release: Boehringer Ingelheim and 3T Biosciences Enter into a Second Partnership to Develop Next-generation Cancer Immunotherapies". Oxford. 2024-01-04
Merck KGaA. (1/4/24). "Press Release: Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna [Not intended for UK-, US- or Canada-based media]". Darmstadt. 2024-01-04
Moonwalk Biosciences. (1/4/24). "Press Release: Moonwalk Biosciences Launches with $57 Million in Financing to Advance a New Class of Precision Epigenetic Medicines". South San Francisco, CA & San Diego, CA. 2024-01-04
CRISPR Therapeutics AG. (1/3/24). "Press Release: CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Zug & Boston, MA. 2024-01-03
Remix Therapeutics, Inc.. (1/3/24). "Press Release: Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing". Watertown, MA. 2024-01-03
Goldman Sachs Asset Management. (1/3/24). "Press Release: Goldman Sachs Asset Management Raises $650 Million for West Street Life Sciences I". New York, NY. 2024-01-03
Evotec SE. (1/3/24). "Press Release: Evotec Announces CEO Transition. Dr. Werner Lanthaler to Step Down as CEO". Hamburg. 2024-01-03
Bruker Corporation. (1/3/24). "Press Release: Bruker Acquires Electron Microscopy Company Nion". Billerica, MA. 2024-01-03
Remix Therapeutics, Inc.. (1/3/24). "Press Release: Remix Therapeutics Closes $60 Million Financing to Advance REM-422, Pipeline of Small Molecule Therapies Designed to Reprogram RNA Processing to Treat Disease". Cambridge, MA. 2024-01-03
Apollo Therapeutics. (1/2/24). "Press Release: Apollo Therapeutics Announces Second Close of Series C Financing Bringing Total Raised in Round to $260 Million". Cambridge & Boston, MA. 2024-01-02
Allorion Therapeutics Inc.. (1/2/24). "Press Release: Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca". Natick, MA. 2024-01-02
ImmunityBio, Inc.. (1/2/24). "Press Release: ImmunityBio Announces $320 Million Investment by Oberland Capital, with $210 Million Funded at Closing, Bringing Total Financing in 2023 to $850 Million". Culver City, CA. 2024-01-02
Tome Biosciences, Inc.. (1/2/24). "Press Release: Tome Biosciences Acquires Replace Therapeutics". Watertown, MA. 2024-01-02
MediLink Therapeutics (Suzhou) Co., Ltd.. (1/2/24). "Press Release: MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to Develop Next-generation Antibody Drug Conjugate in Oncology". Suzhou. 2024-01-02
Roche. (12/29/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire LumiraDx's Point of Care Technology Combining Multiple Diagnostic Modalities on a Single Platform". Basel. 2023-12-29
Chimerix, Inc.. (12/29/23). "Press Release: Chimerix Appoints Lisa Decker to Board of Directors". Durham, NC. 2023-12-29
PAI Partners S.A.S.. (12/27/23). "Press Release: PAI Partners Enters into Agreement for the Sale of ELITech Group to Bruker Corporation". 2023-12-27
Eli Lilly and Company. (12/27/23). "Press Release: Lilly Completes Acquisition of Point Biopharma". Indianapolis, IN. 2023-12-27
Bristol Myers Squibb Company. (12/26/23). "Press Release: Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio". Princeton, NJ & San Diego, CA. 2023-12-26
Bruker Corporation. (12/26/23). "Form 8-K. Current Report [Acquisition of Elitech Group by Bruker for €870m from PAI Partners] CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest eve 2023-12-26
AstraZeneca plc. (12/26/23). "Press Release: AstraZeneca to Acquire Gracell, Furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". 2023-12-26
Gracell Biotechnologies Inc.. (12/26/23). "Press Release: Gracell Biotechnologies to Be Acquired by AstraZeneca, furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". San Diego, CA, Suzhou & Shanghai. 2023-12-26
GenSight Biologics S.A.. (12/22/23). "Press Release: GenSight Biologics Appoints Laurence Rodriguez as Chief Executive Officer". Paris. 2023-12-22
Bristol Myers Squibb Company. (12/22/23). "Press Release: Bristol Myers Squibb to Present at J.P. Morgan’s 42nd Annual Healthcare Conference". Princeton, N.J.. 2023-12-22
Bristol Myers Squibb Company. (12/22/23). "Press Release: Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics". Princeton, N.J. & Boston, MA. 2023-12-22
Remix Therapeutics, Inc.. (12/21/23). "Press Release: Remix Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference". Watertown, MA. 2023-12-21
UPM Biomedicals. (12/21/23). "Press Release: UPM Biomedicals Enters into Distribution Agreement with Brinter for GrowInk Bioinks". 2023-12-21
ITM Isotope Technologies Munich SE. (12/21/23). "Press Release: ITM to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Garching. 2023-12-21
Hookipa Pharma Inc.. (12/21/23). "Press Release: Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences". New York, NY & Vienna. 2023-12-21
Reig Jofre. (12/20/23). "Press Release: Appointment of Laura Martí as Chief Financial Officer (CFO)". Barcelona. 2023-12-20
1 2 3 ... 75 76 77  next pagenext page


Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x300px

» top